MedPath

How well hypopressive exercises work to reduce urine leakage in women who play high-impact sports

Not yet recruiting
Conditions
Urethral functional and muscular disorders,
Registration Number
CTRI/2025/05/086808
Lead Sponsor
Self
Brief Summary

Participants will be screened based on defined inclusion and exclusion criteria. Eligible female athletes will be selected and informed consent will be obtained. Participants will then be divided into two groups. Group A will perform hypopressive exercises and will serve as the intervention group. Group B will perform Kegel exercises and will serve as the control group.

Before starting the intervention, all participants will undergo a pre-test assessment. This will include the International Consultation on Incontinence Questionnaire Short Form, a one-hour pad test for urinary incontinence, and the Incontinence Quality of Life Questionnaire. Baseline scores will be recorded for both groups.



The intervention will last for eight weeks. Group A will follow the hypopressive exercise protocol. Sessions will be conducted twice per week, each lasting 30 minutes. These will be supervised training sessions focusing on posture and breathing techniques. The protocol will include spine elongation, chin retraction, shoulder joint activation, neutral pelvic alignment, ankle dorsiflexion, gravity shift, diaphragmatic breathing, and expiratory apnea. Exercises will be performed in various positions including supine, sitting, standing, kneeling, quadruped, and crook lying. Each session will consist of three sets of three repetitions.



Group B will follow a standard protocol of Kegel exercises targeting pelvic floor muscle strengthening.



After eight weeks, a post-test assessment will be conducted. The same tools used in the pre-test assessment will be administered again. These include the International Consultation on Incontinence Questionnaire Short Form, the one-hour pad test, and the Incontinence Quality of Life Questionnaire. Post-test scores will be compared with baseline scores to evaluate the effectiveness of the intervention.



The key parameters of the study include a frequency of two supervised sessions per week, with a focus on posture correction, breath control, and progressive muscle activation. The main objective is to reduce intra-abdominal pressure, strengthen pelvic floor muscles, and improve posture and core stability.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • Players with High impact sports.
  • Women diagnosed with stress urinary incontinence in response to the items of (1 2 3) for stress score [questionnaire for female urinary incontinence diagnosis (QUID)].
Exclusion Criteria
  • Players who have undergone surgical treatment for abdominal, gynecological and urological treatment in recent times( 1 year).
  • Abdominal or inguinal hernias.
  • Players are having fractures to the ribs, upper limb, lower limbs and trunk.
  • Recurrent urinary tract infections.
  • Players who are under other treatment for SUI.
  • Pelvic malignancy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
International consultation for incontinence questionnaire (ICIQ – SF) (Reliability – 0.93)•International consultation for incontinence questionnaire (ICIQ – SF) (Reliability – 0.93)• Question no:1 2 3 | Pad test for incontinence 1 hour(Reliability- 0.65). | Weight of pad is measured change in weight mare than 0.5 grams.
Pad test for incontinence 1 hour(Reliability- 0.65)International consultation for incontinence questionnaire (ICIQ – SF) (Reliability – 0.93)• Question no:1 2 3 | Pad test for incontinence 1 hour(Reliability- 0.65). | Weight of pad is measured change in weight mare than 0.5 grams.
Secondary Outcome Measures
NameTimeMethod
Incontinence quality of life questionnaire ( Reliability- 0.93)8 weeks

Trial Locations

Locations (1)

SRM sports complex

🇮🇳

Chennai, TAMIL NADU, India

SRM sports complex
🇮🇳Chennai, TAMIL NADU, India
Poojitha reddy
Principal investigator
9948862292
poojithareddy4501@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.